The "Elevate" by MAPS Podcast

The Learning Objectives for this podcast are to understand the scope and requirements of the main privacy laws and regulations, covering data types and processing activities including collection, usage, data retention, subjects’ rights and much more. This podcast also considers the risks and practical application of the regulations in the conduct of various Medical Affairs activities.

This podcast looks at the identification and mitigation of risks in four examples of activities at the Medical/Commercial interface with the intent of strengthening your understanding of how to conduct these activities in a compliant manner. The examples include Medical/Commercial field interactions, patient support programs, advice seeking, and use of artificial intelligence.

From chatbots and content generation to insights mining and decision support, GenAI is moving from buzzword to backbone. In this "Elevate" episode, our hosts Jennifer Riggins & Steve Casey speak to a panel of experts on the frontlines of GenAI implementation to share their hard-won insights.

In this podcast episode, our experts dive into the importance of storytelling in scientific communication, emphasizing the need to balance creativity with accuracy and personalize content for different audiences.

This podcast will provide an overview of results of a poster presented at MAPS Americas in 2025. The title of the poster was "One Team, One Voice: The Impact of Centralized Medical Content Development" and includes results from a survey that was conducted to better understand Medical Affairs (MA) professionals’ strategies for medical content development, utilizing centralized versus dece...

When is the right time to bring your medical information system in-house? What needs to happen once you get there? In this podcast, we dive into scPharmaceuticals’ experience and discuss the milestones that signal a shift. Hear about the case for change, navigating the transition, and the crucial role technology plays in enabling long-term success.

AI offers tremendous benefits but creates new challenges for licensing and research integrity that medical publishers must address. In this MAPS podcast episode, we will discuss the opportunities and challenges of AI in scientific publishing and considerations for medical education.

Expedited publications are essential for rapidly disseminating research findings and accelerating drug approval processes, particularly during public health emergencies. This approach encompasses efficient manuscript development, expedited reviews, and prioritized submissions to scientific journals, ultimately ensuring that critical data swiftly reaches the healthcare community. The urgency for ti...

The Times Higher Education recently reported that Bluesky has overtaken X in hosting posts related to new academic research. And yet many Medical Affairs teams aren't equipped to maximize the potential of this emerging resources. Here we speak with Mike Taylor, Head of Data Insights, at Altmetric, and Carlos Areia, Senior Data Scientist at Altmetric about the uses of Bluesky in comparison wit...

Believe it or not, the field of Kardashian studies can inform the ways Medical Affair professionals identify and understand influencers and influence in the space of science communications. Here we talk with Mike Taylor, Head of Data Insights at Altmetric, and Carlos Areia, Senior Data Scientist at Altmetric about making sense of what is otherwise certainly nonsense. 

In this podcast episode, we share insights from the Wiley annual healthcare professionals survey and interviews on the sources of information they seek and trust. You will learn about how their content needs and preference are evolving and the factors driving their information choices and educational needs. A must listen for those looking to advance their HCP engagement with practical tips to enha...

AI and Generative AI seem to be a part of every webinar, conference, and conversation these days.  Most of you are probably experimenting with AI for personal use and may even be having success with the use of AI in your day-to-day work.  However, the technology and use cases are ever-evolving.  Today's podcast will explore three proof-of-concept (POC) use cases from recent work in the field...

In this podcast, we explore how digitally active HCPs and emerging experts can amplify the impact of scientific data presented at congresses to drive successful drug launches. Industry experts from Pfizer and Veeva discuss strategies for engaging these key influencers to optimize launch success.

Overcoming regional disparities to ensure successful IEGP development and implementation requires effective strategies for cross-functional collaboration across diverse regions and departments. In this podcast, experts explore the many challenges associated with the operationalization of global Integrated Evidence Generation Planning (IEGP) at local levels.

This podcast speaks with experts from Altmetric to delve into different methods for extracting insights to comprehend the influence of a publication on key metrics such as citations, public engagement, social impact, and internal metrics. The aim is to speed up the evaluation process to determine if publications are effectively reaching and educating the appropriate HCPs to influence their clinica...

 This session takes a closer look at one of the key challenges associated with integrated evidence generation planning that was identified in our first installment. Experts share insights and practical advice on ways to identify and overcome barriers to aligning multiple functions in the development and implementation of integrated evidence generation plans to minimize risk and optimize value, acc...

Recorded at the MAPS 2024 Annual Meeting in Puerto Rico following a workshop on modular content in which all of today’s speakers were faculty.   Lead by the Digital FAWG’s Jennifer Riggins and Steve Casey, today’s panelists touch on the topic of modular content in the following areas:   Inspiration and Impact Content Compliance & Approval MSL Utilization Training & Evolution The Technology...

As the sources of data and technologies needed to make sense of data expand, opportunities exist for further integrating Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) alongside traditional approaches when planning data generation activities to support new product registration, access, and use. Here we speak with experts from Lumanity about the Integrated Evidence Gene...

Here we speak with Kate Davies, Nurse Educator at London South Bank University and expert in clinical endocrine research focusing on genetics in short stature, clinical trials, and differences in sex development. Throughout Kate's research and work as a pediatric nurse, she has developed expertise in engaging with patient communities, often providing trusted information to these groups and al...

Getting the most impact from a publication requires being able to define who the audience is and how to reach them, across both journals and online channels, especially in complex/niche cases. In this podcast, we’ll discuss the benefits of taking an analytical approach.

When you think about innovation in Medical Affairs, perhaps the first things that come to mind are GenAI or maybe new approaches to KOL network mapping. But what about innovation in the ways we approach the profession itself? What about innovation in how we continue to evolve our own skills and understanding of our roles in industry and beyond? Here we speak with Tim Mikelhashvili, CEO of Amedea P...

A PubMed search on the day this was written finds 36,735 new publications in the last 24 hours. Adding the word “oncology” narrows the number to 4,334. Substituting “lung cancer” for “oncology” results in 534 articles. How many of these do you think your HCPs and KOLs will be able to read before the next batch of publications comes out tomorrow? This is to say that publishing a scientific study or...

Is there a correlation between a higher journal impact factor and increased reach and engagement? The answer has always been, "Of course!" But now with companies driving their own engagement, and alternatives to the journals becoming more mainstream and accepted everyday, the answer is more nuanced. Join our expert guests from Digital Science to discuss the NEW metrics of journal publica...

In this podcast, we discuss a data-driven approach for optimizing congress planning and execution. MAPS speaks with experts from United Therapeutics and Veeva for tips on finding the right events, effectively engaging the right experts, and enabling medical teams to do more with less.

When Medical Affairs was a support function, it was enough to count the actions we performed to aid the missions of our collaborators in Commercial and R&D. Now that Medical is a strategic partner alongside these other functions, we must measure and message our OWN mission. But how can we draw a line of causality or at least contribution from actions to impact? Here we speak with Diana Morgens...